Literature DB >> 3104482

Experimental transmission of non-A, non-B hepatitis by saliva.

K Abe, T Kurata, T Shikata, M Sugitani, T Oda.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3104482     DOI： 10.1093/infdis/155.5.1078

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  6 in total

1.  Clinical guidelines on the management of hepatitis C.

Authors:  J C Booth; J O'Grady; J Neuberger
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

Review 2.  Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups.

Authors:  H L Tillmann; M P Manns
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

3.  High prevalence of HCV-RNA in the saliva cell fraction of patients with chronic hepatitis C but no evidence of HCV transmission among sexual partners.

Authors:  P Fabris; D Infantolino; M R Biasin; G Marchelle; E Venza; V Terribile Wiel Marin; P Benedetti; G Tositti; V Manfrin; F de Lalla
Journal:  Infection       Date:  1999 Mar-Apr       Impact factor: 3.553

4.  Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes.

Authors:  K Koike; K Moriya; K Ishibashi; H Yotsuyanagi; Y Shintani; H Fujie; K Kurokawa; Y Matsuura; T Miyamura
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

5.  Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease.

Authors:  J Haddad; P Deny; C Munz-Gotheil; J C Ambrosini; J C Trinchet; D Pateron; F Mal; P Callard; M Beaugrand
Journal:  Lancet       Date:  1992-02-08       Impact factor: 79.321

6.  Correlation of detectability of hepatitis C virus genome in saliva of elderly Japanese symptomatic HCV carriers with their hepatic function.

Authors:  H Sugimura; H Yamamoto; H Watabiki; H Ogawa; H Harada; I Saitoh; T Miyamura; M Inoue; K Tajima; I Kino
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.